baber/WOPTO huggingface dataset:
Patent CS-244670-B2 (CS)
Title: Production method of aryloxypropanolamines
Inventor: WIEDEMANN FRITZ
IPC: C07D239/42
Filed: 1981-06-16
Abstract: The present invention provides aryloxypropanolamines of the general formula:   <IMAGE>   wherein R1, R2, R3 and R4, which may be the same or different, are hydrogen or halogen atoms or lower alkyl, cyano, carboxamide, hydroxyl, lower acyloxy, lower alkoxy, lower alkenyloxy or aryl lower alkoxy radicals, R5 and R6, which may be the same or different, are hydrogen atoms or lower alkyl radicals, X is a straight or branched alkylene chain containing 2 to 6 carbon atoms, A is a mono-, bi- or tricyclic heteroaromatic or hydroheteroaromatic radical or, when at least one of the symbols R1, R2, R3 and R4 is other than a hydrogen atom, may also be a phenyl radical, with the proviso that when A is a uracil-6-yl radical, the 5-position of the uracil moiety does not contain a hydrogen atom, R7, R8, R9, R10 and R11, which may be the same or different, are mono- or divalent substituents selected from hydrogen, halogen, notro, hydraxylamino, amino, lower acylamino, lower alkylamino, di-(lower alkyl)-amino, hydroxyethylamino, di-(hydroxyethyl)-amino, hydroxyl, lower alkoxy, allyloxy, methoxy lower alkoxy, cyano, carboxamido, carboxy, lower alkoxycarbonyl, hydroxymethyl, lower alkoxymethyl, halomethyl, aminomethyl, lower acylaminomethyl, halomethyl, aminomethyl, lower acylaminomethyl, di(lower alkyl)-aminomethyl, pyrrolidinomethyl, piperidinomethyl, di-(hydroxyethyl)-amino, hydroxyl, lower alkoxy, allyloxy, methoxy lower alkoxy, cyano, carboxamido, carboxy, lower alkoxycarbonyl, hydroxymethyl, lower alkoxymethyl, halomethyl, aminomethyl, lower acyaminomethyl, di-(lower alkyl)-aminomethyl, pyrrolidinomethyl, piperidinomethyl, di-(hydroxyethyl)-aminomethyl, morpholinomethyl, piperazinomethyl, 4-lower acylpiperazinomethyl, 4-lower alkylpiperazinomethyl, lower alkyl, lower alkenyl, 2-cyanoethyl, 2-hydroxyethyl, phenyl lower alkyl and phenyl, the phenyl radicals being optionally substituted with 1 or 2 hydroxyl or methoxy radicals, or from oxygen or sulphur; the optically-active forms and the racemic mixtures thereof, and the pharmacologically compatible salts thereof. The present invention also provides processes for the preparation of these compounds and pharmaceutical compositions containing them. These compounds are useful for the prophylaxis and combatting of cardiac and circulatory diseases.
Patent CS-222695-B2 (CS)
Title: Method of making the new imidodisulphonamide
Inventor: ALI FADIA E
IPC: A61P37/08
Filed: 1981-04-08
Abstract: Imidodisulfamide derivatives of formula (I)
       
     in which X is hydrogen, methyl, bromo or chloro; and Y is a benzeneaminosulfonyl radical of the formula
       
     in which R is hydrogen or methyl; R 1  is hydrogen, bromo, chloro, nitro, methyl, trifluoromethyl or methoxy; and R 2  is hydrogen, chloro or methyl provided that when R 2  is chloro, R 1  is chloro, methyl or trifluoromethyl and when R 2  is methyl, R 1  is methyl; and alkali metal salts of said compounds, which are useful in the treatment of allergic conditions, are prepared by reaction of an appropriately substituted tetrahydroisoquinoline and bis (chlorosulfonyl) imide in the presence of a tertiary amine.
Patent CS-246060-B2 (CS)
Title: Catalytic system for conjugated diolefins polymerization
Inventor: CARBONARO ANTONIO
IPC: C08F4/60
Filed: 1983-04-15
Abstract: A new process is described for polymerising and copolymerising conjugate diolefins, characterised by using a catalytic system formed from at least one metal pertaining to Group IIIB of the Periodic System, at least one non-halogenated aluminium alkyl, at least one organic halogen derivative or a halide of an element also able to exist in a lower valency state, and at least one compound containing one or more salifiable hydroxyl groups, ie of acid or neutral type. The new process allows the preparation, both in the absence and in the presence of inert diluents, of conjugate diolefin polymers of linear structure which are essentially entirely 1,4-cis. The method for preparing the new catalytic system is also described.
Patent CS-207344-B2 (CS)
Title: Method and device for catching and lifting the flabby upper parts from the stack of parts
Inventor: MORTON KENNETH O
IPC: B65H3/22
Filed: 1975-05-19
Abstract: 1511210 Handling limp plies CLUETT PEABODY & CO Inc 6 May 1975 [17 May 1974] 24757/77 Divided out of 1511184 Heading B8R The description is the same as that of the parent Specification but the claims relate to a shutter device 35 which is moved under a lifted ply to receive it and separate any following plies and then transport the separated ply to a conveyer 36. The shutter 35 has positioning lugs 74 and a ball chain 81 may be used to assist in spreading the ply. When positioned over conveyer 36 the ply is held and the shutter 35 returned to its receiving positioning. Alternatively a receiving platform may extend upwards through spaces 130 to collect the ply and then lower it on to conveyer 36. Drag bars 73 and sweep arms 78 may also assist in positioning the ply on shutter 35.
Patent CS-197220-B2 (CS)
Title: Internal combustion engine
Inventor: SAKURAI YOSHITOSHI
IPC: F02B/
Filed: 1973-06-27
Abstract: 1439832 I C engine intake and exhaust conduits; heating charge HONDA GIKEN KOGYO KK 27 June 1973 [28 June 1972] 30554/73 Heading F1B A chamber 22 having outlet conduits 16 for supplying mixture to main combustion chambers 2 and a chamber 23 having outlet conduits 17 for supplying richer mixture to pre-combustion chambers 5 are in good heat-transfer relationship one with another and with a chamber 24 having inlet conduits 18 for receiving exhaust gases from the main combustion chamber. The conduits 16 and 17 have a common wall adjacent their connections to the cylinder head 21, Fig. 2 (not shown).
Patent CS-264108-B2 (CS)
Title: Method for clothes knitting and a circular knitting machine for carrying out the method
Inventor: RICCITELLI IVAN
IPC: D04B9/46
Filed: 1984-09-20
Abstract: Method and Machine for knitting garments having legs and a body portion. 
<??>A circular knitting machine for simultaneously making several pairs of tights and the like, with two tubular legs and a body portion having a front and a back, comprises a movable unit carrying a cylinder (1) with a circle of cylinder needles (14) and a plate (30) carrying an adjacent circle of plate needles (38). The movable unit moves with alternating rotary movement relative to several thread guides (50) disposed around the circles of needles. In order to make several garments simultaneously, the circles are divided into as many arcuate groups of needles as there are garments. Each arcuate group is divided into two equal sub-groups separated by a middle group. The needles of each group are automatically brought into operation in a sequence to knit the toes and legs (on the sub-groups), then the crotch (using the middle group as well), then the body (still using two threads, one for the left-hand and one for the linked right-hand side).
Patent CS-250207-B2 (CS)
Title: Herbicide
Inventor: LEVITT GEORGE
IPC: C07D405/12
Filed: 1980-11-28
Abstract: Ureas and isoureas of the formula
     wherein W' is 0 or
     A' is H, Cl, Br, alkyl, OCH 3 , N0 2  or CF 3 ;   A is a wide variety of ester or thioester groups or derivatives thereof;
     where R 4  is H or CH 3     R 5  is H, CH 3  or OCH 3     WisOorS   R lV  is alkyl or alkenyl; and   R is a pyrimidyl or triazinyl moiety which is optionally substituted;     
exhibit potent herbicidal activity and may be of interest
     for regulating plant growth. The compounds can be formulated for use in conventional manner. They may be prepared by a variety of processes, e.g. by reacting a heterocyclic sulfonyl isocyanate or isothiocvanate of formula
     with an appropriate amine HNR 5 R 1 . 
     Some of the compounds V form a further aspect of the invention. They can be made from the corresponding sulfonamide by reaction with CS 2  and phosgene. 
     Further intermediates of formula
     where R 1  is H or a cation of an alkali metal or tertiary amine are also within the scope of the invention.
Patent AU-782471-B2 (AU)
Title: Method of producing N-(4,5-bis-methanesulfonyl-2-methyl-benzoyl)-guanidine, the hydrochloride thereof
Inventor: GERICKE ROLF
IPC: C07C317/44
Filed: 2000-10-11
Granted: 2005-08-04
Abstract: The present invention relates to an NHE-1 selective Na+/H+ antiporter inhibitor N-(4,5-bismethanesulfonyl-2-methylbenzoyl)guanidine, hydrochloride, to its hydrochloride hydrate, and to a process for the preparation.
Patent AU-610560-B2 (AU)
Title: New 19-norsteroids substituted at the 7-position, their preparation, their application as drugs and the pharmaceutical compositions containing them
Inventor: NIQUE FRANCOIS
IPC: C07J51/00
Filed: 1988-02-17
Granted: 1991-05-23
Abstract: Novel 19-nor-steroids of the formula    <IMAGE>  (I)  wherein the A ring is either   <IMAGE>  Re is selected from the group consisting of hydrogen, acyl and optionally substituted alkyl of 1 to 6 carbon atoms, R is methyl or ethyl, R1 is selected from the group consisting of hydroxyl, protected hydroxyl, acyloxy and alkoxy, R2 is selected from the group consisting of hydrogen, alkyl of 1 to 8 carbon atoms, alkenyl and alkynyl of 2 to 8 carbon atoms, acyl, aralkyl of 7 to 15 carbon atoms, the substituents other than hydrogen being optionally substituted or R1 and R2 together form a group selected from the group consisting of   <IMAGE>   Ar is an optionally substituted 5- or 6-membered aryl and their salts with non-toxic, pharmaceutically acceptable bases and acids having antiproliferative, anti-estrogenic and/or estrogenic properties.
Patent AU-607740-B2 (AU)
Title: A method for the functional determination of protein c inhibitor
Inventor: STIEF THOMAS
IPC: C12Q1/56
Filed: 1988-02-22
Granted: 1991-03-14
Abstract: A method and an agent for the functional determination of protein C inhibitor in body fluids are described, in which this fluid is mixed with a known amount of a plasminogen activator, fibrinogen and a sulphated carbohydrate and incubated and the residual activity of the plasminogen activator is determined and from this the amount of protein C inhibitor is determined.
Patent AU-750995-B2 (AU)
Title: Method and apparatus for detecting an object
Inventor: LLOYD CHRISTOPHER JAMES
IPC: G01B11/00
Filed: 1998-11-25
Granted: 2002-08-08
Abstract: A method of detecting an object located within a dynamic scattering media, includes i) directing a continuous coherent light wave of predetermined wavelength into the media; ii) detecting dynamically scattered light emerging from the media; iii) correlating the detected light photons in the time or frequency domain; iv) determining the presence of an object from analysis of differences between the correlation and a correlation which would arise from photons scattered by the media only; and v) determining the approximate position of the object within the media from the analysis of the correlation and knowledge of the mean transport path of the light wave of predetermined wavelength within the media.
Patent AU-741003-B2 (AU)
Title: Forehead support for facial mask
Inventor: KWOK PHILIP RODNEY
IPC: A61M16/06
Filed: 2000-02-11
Granted: 2001-11-22
Abstract: A forehead support (10) is disclosed that is adapted to be secured to a respiratory mask (16). The forehead support (10) includes a joining member (14) for securing to the mask (16) and a cushion frame (12) pivotally mounted to the joining member (14). The cushion frame (12) is adapted to locate one or more forehead cushions (25). The cushion frame (12) is also adapted to pivot relative to the joining member (14). The cushion frame (12) is also selectively lockable at two or more predetermined angular positions relative to the joining member (14).  A respiratory mask assembly comprising a respiratory mask (16) and a forehead support (10) adapted to be secured to the mask (16) is also disclosed.
Patent AU-692519-B2 (AU)
Title: Microbial decontamination system with components porous to anti-microbial fluids
Inventor: MALCHESKY PAUL S
IPC: A61L2/18
Filed: 1995-01-11
Granted: 1998-06-11
Abstract: A countertop decontamination unit (A) has a decontamination chamber (10) for receiving a tray or module (C) which contains items to be sterilized, disinfected, or otherwise microbially decontaminated. The tray or walls of the decontamination chamber itself provide fluid outlets from which an anti-microbial solution is conveyed through tubing (76) to fittings (78). A pump (20) recirculates the anti-microbial fluid. The fittings include a porous sleeve (80, 92) which is received in firm frictional connection with an annular surface of a bore, nipple, or coupler mechanism of the item (86) to be sterilized. The porous sleeve is preferably elastomeric when used for frictional interconnections, but may be rigid when used with threaded or other standardized connectors. The porous sleeve has a porosity of 3 microns or more, sufficient that the anti-microbial fluid penetrates through the porous portion and contacts the immediately contiguous and abutting annular surface. The porous member permits sufficient quantities of solution to contact these surfaces to assure they are microbially decontaminated. Associated surfaces that contact the item and can potentially trap microbes are also constructed of porous material. Other associated porous structures include porous closures, such as plugs (124, 160) or caps (120, 122) which close some of the access ports to the interior passages of endoscopes, item retainers (68), a bottom wall portion (62), other surfaces of the item (174), and the like.
Patent AU-663710-B2 (AU)
Title: Sewage system
Inventor: BAAR JACOBUS ELDERT MARIA VAN
IPC: E03F1/00
Filed: 1992-04-14
Granted: 1995-10-19
Abstract: PCT No. PCT/NL92/00070 Sec. 371 Date Dec. 9, 1993 Sec. 102(e) Date Dec. 9, 1993 PCT Filed Apr. 14, 1992 PCT Pub. No. WO92/18714 PCT Pub. Date Oct. 29, 1992.Sewage system comprised of a collector pipe with one or more house connections and to which collector pipe an air compressor and/or vacuum pump is connected, wherein a house connection is comprised of a collection gully with a connection for the sewer pipe, and which gully, at its bottom side is provided with a valve, which may be operated under the control of a level switch arranged in the gully, while the valve at the discharge side is connected to the collected pipe which at that place is provided with a bend situated in a vertical plane, to the middle part of which the valve is connected and from which both the sideways running bend parts run upwards to a height below the valve.
Patent AU-768525-B2 (AU)
Title: Anti-inflammatory oxo derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical use
Inventor: LAUFER STEFAN
IPC: A61P29/00
Filed: 1999-11-23
Granted: 2003-12-18
Abstract: 1-(Hydroxy, alkoxy, acyloxy or oxo)-6,7-di(hetero)aryl-pyrrolizine derivatives are new.  Pyrrolizine derivatives of formula (I) and their optical isomers, salts and physiologically hydrolysable esters are new: R1, R2  =  aryl or mono- or bicyclic heteroaryl containing 1-3 N, O and/or S atoms (each optionally substituted by 1-3 alkyl, halo, CF3, alkoxy, aryloxy and/or CN and optionally fused with phenyl or naphthyl); R3  =  H; alkyl; COOH; COO-alkyl; COO-Alk-phenyl; COCOOH; COCOO-alkyl; CHO; or A-Y;  A  =  1-8C alkylene or 2-8C alkenylene optionally substituted by OH or alkoxy;  Y  =  COOH; SO3H; OPO(OH)2; OP(OH)2; tetrazolyl; COO-alkyl; SO3-alkyl; CHO; or OH;  Alk  =  1-4C alkylene;  R4-R7  =  H or alkyl;  one of R8 and R9  =  H or alkyl; and the other is OH; alkoxy; or acyloxy; or  R8  + R9 = oxo.
Patent AU-658419-B2 (AU)
Title: Hydrodynamic bearings having spaced bearing pads and methods of making same
Inventor: IDE RUSSELL D
IPC: F16F15/023
Filed: 1992-04-15
Granted: 1995-04-13
Abstract: A hydrodynamic thrust, journal or combined radial and thrust bearing. The bearing includes a bearing pad structure that may change shape and move in any direction (six degrees of freedom) to optimize formation of a converging wedge for hydrodynamic operation, equalization of load on the bearing pads in thrust bearings and to adjust for any shaft misalignment. The bearing pad (12) may be formed so as to contact the shaft in the installed state and to deflect under fluid film pressure. The shape of the pads (12) may be altered to achieve desired deformations under load. The pads are supported by a support structure which can include one or more beam-like members (14).
Patent AU-614525-B2 (AU)
Title: Blood substitutes
Inventor: HOFFMAN STEPHEN J
IPC: C12R1/19
Filed: 1988-05-13
Granted: 1991-09-05
Abstract: Solutions of mutant hemoglobins having a lower oxygen affinity than that of native hemoglobin are used as blood substitutes. The mutant hemoglobins are preferably obtained by recombinant DNA techniques. Both alpha and beta globin chains can now be so prepared, making possible the production of wholly artificial hemoglobin, whether conventional or mutant in form. Solutions of wholly artificial hemoglobins are also used as blood substitutes.
Patent AU-616195-B2 (AU)
Title: Lectines fixing beta-d-galactoside
Inventor: STROSBERG ARTHUR DONNY
IPC: C07K14/42
Filed: 1988-07-18
Granted: 1991-10-24
Abstract: The present invention relates to amino acid sequences reproducing at least in part the sequence of animal and human lectines. The sequence of amino acids comprises a skeleton which is comprised of at least the following amino acids and in the following positions:  <IMAGE> . Application particularly to the diagnostic of tumoral affections.
Patent AU-665012-B2 (AU)
Title: Novel growth factor-responsive progenitor cells which can be proliferated (in vitro)
Inventor: WEISS SAMUEL
IPC: A61K35/30
Filed: 1992-07-07
Granted: 1995-12-14
Abstract: An in vitro culture system for the perpetuation of an unlimited number of neural progenitor cells. Progenitor cells are isolated from particular neural regions and proliferated in suspension cultures in the presence of growth factors. The progenitor cells can be induced to differentiate into neurons and glial cells. The ability to perpetuate fetal progenitor cells allows for production of a large supply of tissue from a minimal number of fetuses for transplantation into an animal with neurodegeneration. The use of juvenile and adult cells for generating progenitors would eliminate the need to obtain fetal tissue and may allow for patient to supply his own progenitors. Such an approach would eliminate the ethical problem of obtaining fetal neuronal tissue as well as the problem of tissue rejection and the required use of immunosuppressive drugs.
Patent AU-555127-B2 (AU)
Title: Aqueous enzyme-containing compositions
Inventor: BOSKAMP JELLES VINCENT
IPC: C11D3/386
Filed: 1984-04-19
Granted: 1986-09-11
Abstract: The invention pertains to aqueous, enzymatic liquid detergent compositions which contain an enzyme-stabilizing system. The replacement of polyols in known enzyme-stabilizing systems on the basis of mixtures of a polyol with a boron compound, such as boric acid or borax, or with a reducing salt, such as sodium sulphite, by a dicarboxylic acid, such as succinic acid, also provides for an effective, often superior enzymestabilizing system.
Patent AU-780366-B2 (AU)
Title: Preparation and xenotransplantation of porcine islets
Inventor: ELLIOTT ROBERT BARTLET
IPC: A61K35/12
Filed: 2001-01-19
Granted: 2005-03-17
Abstract: The invention relates to developments in the treatment of diabetes in mammals. Particularly it relates to a method of preparing a xenotransplantable porcine islet preparation capable upon xenotransplantation of producing porcine insulin in an appropriate recipient mammal, the method including or comprising the steps of: (I) harvesting the pancreas of piglets at or near full term gestation, and (ii) extracting pancreatic β islet cells from the harvested pancreas wherein the islets (at least at some stage in the performance of the method) are exposed to nicotinamide. Further, the invention relates to a method of encapsulation of a xenotransplantable porcine islet preparation, and transplantation of such a preparation, or a capsule containing such a preparation, into an appropriate recipient mammal.
Patent AU-757006-B2 (AU)
Title: Method of carrying out electrochemical reactions
Inventor: COOLEY GRAHAM EDWARD
IPC: H01M8/08
Filed: 2000-01-19
Granted: 2003-01-30
Abstract: A method of carrying out an electrochemical reaction which comprises including in suspension in the electrolyte in the positive chamber and/or in the electrolyte in the negative chamber an electrocatalyst for the electrochemical reaction, the electrocatalyst having a particle size of up to 1 micrometre in diameter. The electrochemical process may be used in energy storage/power delivering cells employing circulating electrolyte.
Patent AU-713546-B2 (AU)
Title: Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
Inventor: WARREN KENNETH G
IPC: A61K38/08
Filed: 1995-10-20
Granted: 1999-12-02
Abstract: Human myelin basic protein (h-MBP) has a molecular weight of 18.5 KD and contains 170 amino acid residues. Synthetic peptides ranging in length from about 8 to 25 residues and covering the entire length of the protein have been produced. Antibodies to h-MBP (anti-MBP) were found to be neutralized by the synthetic peptides, in vitro, which span the h-MBP from about amino acid residue 61 to about amino acid residue 106. The peptides, which cover both the amino (about residues 1 to 63) and carboxy (about residues 117 to 162) terminals of h-MBP did not neutralize purified anti-MBP. Intrathecal administration of peptide MBP75-95, either as a single dose, or as repeated injections for periods up to 10 weeks, produced complete binding-neutralization of free (F) anti-MBP with no change in bound (B) levels. A control peptide MBP35-58 had no effect on F or B anti-MBP levels. Intravenous administration of MBP75-95 resulted in significant decline of F and B CSF anti-MBP levels over a period of one month. Administration of MBP synthetic peptides to MS patients either intrathecally or intravenously did not have any adverse neurological effects and systemic complications did not occur. The MBP epitope for MS anti-MBP has been localized to an area between Pro85 and Pro96.
Patent AU-670434-B2 (AU)
Title: User activated iontophoretic device and method for using same
Inventor: EVERS HANS CHRISTER ARVID
IPC: A61N1/30
Filed: 1993-03-17
Granted: 1996-07-18
Abstract: The iontophoretic device or patch (10) of the present invention includes an electrode assembly (12), having at least one electrode, an electrode reservoir (14) and at least one drug reservoir (16), which are held or contained within a pouch or other suitable structure (18). It should be appreciated that a return electrode may be combined in the assembly (12) or separately provided as is well known in the art. The device is divided or otherwise separated into two portions, one portion (20) (first) includes the electrode assembly (12) and the electrode reservoir (14) with the electrode reservoir being situated adjacent to the electrode assembly and holding an electrolyte (26). The other portion (22) (second) includes the drug reservoir (16) which holds the medication or drug (28), preferably in an ionized or ionizable form, to be delivered iontophoretically.
Patent AU-629561-B2 (AU)
Title: Optical components
Inventor: MUSK ROBERT WILLIAM
IPC: H01L33/00
Filed: 1989-07-12
Granted: 1992-10-08
Abstract: A method of making an opto-electronic component (13) comprises inserting a pre-assembled device carrier (1) into a mould, filling the mould (2) with light and/or thermally curable material, optically aligning the device assembly and, on achieving optical alignment, at least partially curing the material.